Figure 2From: Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritisComparative changes in the disease-activity score DAS28 during the 2 years of follow-up in early RA patients who are positive and negative for anti-CFFCP and anti-CCP2 at baseline. Anti-CFFCP1 (n = 101), anti-CFFCP2 (n = 98), anti-CFFCP3 (n = 98), and anti-CCP2 (n = 109). Mean values are presented. *P < 0.05.Back to article page